IOSAT™ Potassium Iodide Expires 04/2032

Description

Would you rather be one year to early than 1 minute to late?

Several internet-based companies have been marketing potassium iodate (KIO3) for radiation protection in place of potassium iodide (KI). Though the names are similar, the products are very different. Regulators have expressed serious concerns about the safety and effectiveness of iodate, and the fact that its manufacturers are not in conformity with regulations to assure safety, quality and purity of the product. Regulators have sent cease and desist letters to some of these manufacturers who recommend their iodate product for radiation emergencies.

• IOSAT™ Potassium Iodide is the only brand tested and approved for radiation emergencies.
• IOSAT™ Potassium Iodide is the ONLY adult full-strength tablets for radiation protection that have passed all FDA tests for purity, quality, safety, and efficacy. Approved 130mg and 65mg tablets for use by adults and children in a radiation emergency.
• IOSAT™ Potassium Iodide 10 year shelf-life

With the threat of nuclear war, or attacks on nuclear reactors constantly making headlines, or accidents a little bit of security is better than none at all. It’s better to be 1 year to early than 1 minute to late.

• The Need for Thyroid Protection: Thyroid cancer, especially among children, is the most common and dangerous effect from radiation exposure. More than 90% of the cancer at Chernobyl was thyroid related[i]. Thyroid damage was seen more than 200 miles downwind[ii]. Thousands of cases are known[iii].
• Proven Safe and Effective: KI’s value was demonstrated at Chernobyl. More than 18 million people received the drug,[iv] and all were protected. But in areas where KI was not available, thyroid damage, including cancer, among children spiked to epidemic rates. All preventable.
• Who is at Risk? Radioactive fallout, from power plants or weapons, can travel long distances. Almost all of the thyroid cancer from Chernobyl took place more than 30 miles from the reactor.[v] Millions were threatened and thousands developed cancer.

How to use KI
Each tablet of iOSAT contains 130 mg of potassium iodide in a small round tablet. The tablet is scored to aid in splitting it into 65 and 32.5 mg doses for young children (or small pets). In an emergency, adults are encouraged to take one full tablet. Children under 18 can receive an effective dose from half a tablet. However, KI is known to be very safe for children, so any child over the age of one could take a full tablet with no adverse consequences expected. (This makes emergency administration easier.)

When to use KI
iOSAT does not cure thyroid cancer. It prevents it by blocking RAI. Therefore, it is important to take KI as early as possible. If taken right before exposure to RAI, almost complete protection is assured.

KI works for about 24 hours, so one dose should be taken daily for as long as RAI remains in the environment. In heavily contaminated areas, say within 50 miles of a release from a nuclear powerplant or nuclear weapon, the danger period for the RAI to decay could be as long as 40 to 60 days.

While maximum effectiveness is gained by taking KI at or just before initial exposure, significant protection is available even if taken later than this. Beginning KI administration at ANY TIME during the danger period will block entry of RAI for the remaining balance of the danger period.

Precautions
Side effects from potassium iodide are extremely rare, but it should not be used by anyone with a known allergy to the drug, or those with nodular thyroid disease, hypocomplementemic vasculitis, or dermatitis herpetiformis. The drug is approved for children and pregnant women, but people on other thyroid medicines should alert their physician if they take KI.

[i] More than 90% of the cancer at Chernobyl was thyroid related [10 years after the accident] “except for thyroid cancer, there has been no confirmed increase in the rates of other cancers, including leukemia” FROM: “Assessment of the Use of Potassium Iodide (KI) as a Public Protective Action During Severe Reactor Accidents” US Nuclear Regulatory Commission, Released as Draft NUREG-1633, page 15
[ii] Thyroid damage was seen more than 200 miles downwind [At Chernobyl] “The increase [in thyroid cancer] has been documented up to 500 km from the accident site.” FROM: “Guidelines for Iodine Prophylaxis following Nuclear Accidents”, World Health Organization, Page 5
[iii] Thousands of cases are known “About 6000 thyroid cancer cases have been detected “ U.S. Nuclear Regulatory Commission, Office of Public Affairs, “BACKGROUNDER”, April, 2012
[iv] More than 18 million people received the drug SEE: “Iodine Prophylaxis in Poland After the Chernobyl Reactor Accident: Benefits and Risks”. The American Journal of Medicine, May 1993, Volume 94, page 524
[v] “Almost all of the thyroid cancer from Chernobyl took place more than 30 miles from the reactor”